The House Committee on Energy and Commerce discussed FDA’s user fee budget and what can be done to reshore more of the pharmaceutical industry.
CPA sent the following letter to House Speaker Nancy Pelosi (D-CA) and Minority Leader Kevin McCarthy (R-CA) regarding the Office of the Attending Physician’s distribution of KN95 masks made in China to lawmakers. CPA urged House leadership to immediately stop all purchase and procurement of Chinese personal protective equipment (PPE) and instead source from American…
Recent supply chain bottlenecks of hospital gear shows why continued dependence on Asia is bad for pandemic preparedness. The Make PPE in America Act in the infrastructure law should remedy this in the years ahead, if Congress doesn’t open the doors to duty-free PPE and undercut the law’s intent.
Free trade loses out to a bigger government role in securing domestic supply chains of critical medication.
WASHINGTON — The Coalition for a Prosperous America (CPA) today applauded U.S. Senators Sherrod Brown (D-OH) and Tammy Baldwin (D-WI) for leading a letter to United States Trade Representative (USTR) Katherine Tai requesting that 301 penalty duties be assessed to all imported finished state personal protective equipment (PPE) and key raw material inputs, including single-use…
CPA’s report, titled “Generic Drug Shortages and How a Race to the Bottom in Price has Upended 30 years of Hatch-Waxman,” details how a loophole in the Hatch-Waxman Act has led to generic drug shortages in the U.S., offshoring of America’s domestic production of generic pharmaceuticals to China and India, and price gouging by foreign…
WASHINGTON — The Coalition for a Prosperous America (CPA) today released a new academic report that details how a loophole in the Hatch-Waxman Act has led to generic drug shortages in the U.S., offshoring of America’s domestic production of generic pharmaceuticals to China and India, and price gouging by foreign companies in the U.S. The…
Both houses of Congress have bills that have passed committees, easily, in regard to building domestic supply of personal protective equipment for medical staff. These bills need to hit the floor so President Biden can sign them. But, more importantly, Buy American provisions face serious WTO risk, making all of this action moot.
How do we bring back generic drug manufacturing to the United States in order to be less reliant on India, China? A National Academies of Science conference brings in some experts to try and answer that, including the chair of CPA Healthcare Committee.
The trend continues. A Chinese couple indicted over biotech trade secret’s lifted from Ohio research hospital.
